Arrowhead Pharmaceuticals, Inc. Financial Ratios — 0HI3

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Return on Common Equity (%)	-28.66	-185.28	-166.05	-60.43	-66.45	-79.44	-38.85	-61.45	39.94	-23.94	-32.36	-43.62	-61.29	-262.48	-0.5
Return on Assets (%)	-22.16	-130.34	-115.65	-53.26	-58.36	-62.76	-29.61	-50.5	29.46	-19.39	-22.85	-25.11	-28.17	-62.93	-0.13
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	39.8	- -	- -	- -	- -	- -	2.4
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	35.73	- -	- -	- -	- -	- -	7.31
Gross Margin (%)	100	100	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	-3,228.99	-13,167.82	-7,867.91	-29,674.65	-24,512.5	-49,568.11	-102.86	-317.41	38.88	-99.12	-101.79	-69.11	-79.97	-16,403.41	14.74
Operating Margin (%)	-3,319.48	-14,358.61	-8,020.65	-29,202.23	-25,124.08	-50,331.84	-117.79	-346.52	36.25	-105.87	-107.77	-73.39	-85.16	-16,927.06	11.86
Incremental Operating Margin (%)	- -	7,542.97	- -	24,137.79	- -	- -	136.63	124.07	76.73	191.02	- -	- -	1,061.5	166.99	84.69
Pretax Margin (%)	-2,966.52	-15,054.05	-10,922.08	-33,554.35	-24,067.67	-51,613.12	-109.46	-337.3	40.37	-96.09	-101.85	-71.01	-85.78	-17,247.54	6.21
Profit Margin (%)	-1,056.56	-14,383.61	-10,729.22	-33,502.97	-24,068.29	-51,614.64	-109.46	-337.32	40.27	-96.09	-101.85	-72.39	-85.27	-16,882.37	-0.2
Net Income to Common Margin (%)	-1,056.56	-14,383.61	-10,729.22	-33,502.97	-24,068.29	-51,614.64	-109.46	-337.32	40.27	-96.09	-101.85	-72.39	-85.27	-16,882.37	-0.2
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.26	- -	- -	- -	- -	- -	41.56
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-28.66	-185.28	-166.05	-60.43	-66.45	-79.44	-38.85	-61.45	39.94	-23.94	-32.36	-43.62	-61.29	-262.48	-0.5

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Total Debt	1	2	2	1	1	3	3	2	- -	21	26	82	115	511	366
ST Debt	- -	- -	1	- -	- -	- -	- -	- -	- -	1	2	3	11	6	47
LT Debt	1	2	1	1	1	3	2	2	- -	20	23	79	105	504	319
Total Debt/EBITDA	-0.06	-0.13	-0.1	-0.02	-0.01	-0.03	-0.08	-0.05	- -	-0.24	-0.18	-0.49	-0.6	-0.88	3
Net Debt/EBITDA	0.72	0.13	0.79	2.55	0.87	1.05	0.69	0.54	-3.38	1.65	1.31	0.64	0.58	-0.54	1.36
Total Debt/EBIT	-0.06	-0.12	-0.09	-0.02	-0.01	-0.03	-0.07	-0.04	- -	-0.23	-0.17	-0.46	-0.56	-0.85	3.72
Net Debt/EBIT	0.7	0.12	0.74	2.49	0.85	1.01	0.6	0.5	-3.62	1.54	1.24	0.61	0.54	-0.53	1.69
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-10.5	-18	1.37
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-20.15	-22.38	1.11
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-11.19	-18.58	1.1
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	18	32	89
Common Equity/Total Assets	80.51	60.58	73.66	91.1	83.3	74.57	78.27	85.83	69.91	88.38	57.57	57.59	35.44	16.27	33.64
Long-Term Debt/Equity (%)	4.83	24.09	4.32	0.46	0.49	2.67	2.88	2.21	- -	4.34	5.7	18.84	36.43	263.9	63.37
Long-Term Debt/Capital (%)	4.61	18.87	3.96	0.45	0.49	2.59	2.79	2.15	- -	4.15	5.36	15.76	26	71.86	36.68
Long-Term Debt/Total Assets (%)	3.82	12.84	2.98	0.41	0.41	1.98	2.24	1.88	- -	3.84	3.28	11.39	13.66	44.24	23.03
Total Debt/Equity (%)	4.83	27.66	8.95	0.62	0.69	2.87	3.13	2.44	- -	4.58	6.25	19.5	40.11	267.22	72.76
Total Debt/Capital (%)	4.61	21.67	8.22	0.61	0.69	2.79	3.04	2.38	- -	4.38	5.88	16.32	28.63	72.77	42.12
Total Debt/Total Assets (%)	3.82	14.74	6.17	0.56	0.57	2.13	2.44	2.08	- -	4.05	3.6	11.79	15.04	44.79	26.44
Net Debt to Equity	-54.92	-27.68	-70.31	-79.8	-74.09	-86.97	-27.58	-29.2	-90.89	-31.09	-45.11	-25.82	-38.62	165.9	33.01
Net Debt/Capital (%)	-121.84	-30.98	-202.74	-383.98	-278.46	-667.22	-38.09	-41.24	-997.67	-42.31	-73.79	-27.56	-38.05	50.68	21.28
EBITDA	-10	-19	-23	-52	-94	-78	-32	-51	66	-87	-141	-168	-193	-582	122
EBITDA-CapEx	-10	-20	-23	-54	-96	-82	-40	-53	54	-99	-164	-221	-369	-724	100
Operating Income (Loss)	-10	-21	-23	-51	-96	-80	-37	-56	61	-93	-149	-179	-205	-601	98

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Cash Ratio	3.15	0.65	3.23	13.01	6.21	3.33	3.51	6.19	2.67	7.76	2.51	2.71	3.83	6.6	4.7
Current Ratio	3.82	1.23	3.31	13.07	6.47	3.53	3.63	6.37	2.73	7.92	2.62	2.92	3.95	6.74	4.86
Quick Ratio	3.78	1.12	3.23	13.01	6.21	3.33	3.51	6.22	2.67	7.78	2.58	2.72	3.83	6.6	4.74
CFO/Avg Current Liab	-1.57	-3.88	-2.71	-3.44	-4.74	-3.1	-1.08	-3.04	3.16	-1.39	1.83	-0.95	-1.26	-4.44	1.2
Common Equity/Total Assets	80.51	60.58	73.66	91.1	83.3	74.57	78.27	85.83	69.91	88.38	57.57	57.59	35.44	16.27	33.64
Long-Term Debt/Equity (%)	4.83	24.09	4.32	0.46	0.49	2.67	2.88	2.21	- -	4.34	5.7	18.84	36.43	263.9	63.37
Long-Term Debt/Capital (%)	4.61	18.87	3.96	0.45	0.49	2.59	2.79	2.15	- -	4.15	5.36	15.76	26	71.86	36.68
Long-Term Debt/Total Assets (%)	3.82	12.84	2.98	0.41	0.41	1.98	2.24	1.88	- -	3.84	3.28	11.39	13.66	44.24	23.03
Total Debt/Equity (%)	4.83	27.66	8.95	0.62	0.69	2.87	3.13	2.44	- -	4.58	6.25	19.5	40.11	267.22	72.76
Total Debt/Capital (%)	4.61	21.67	8.22	0.61	0.69	2.79	3.04	2.38	- -	4.38	5.88	16.32	28.63	72.77	42.12
Total Debt/Total Assets (%)	3.82	14.74	6.17	0.56	0.57	2.13	2.44	2.08	- -	4.05	3.6	11.79	15.04	44.79	26.44
CFO/Total Liabilities	-162.16	-198.74	-164.15	-210.42	-290.15	-194.34	-103.39	-288.49	163.53	-157.76	56.85	-49.76	-32.17	-48.79	20.36
CFO/CapEx	-557.24	-31.98	-64.11	-20.62	-33.34	-16.69	-3.02	-33.23	14.42	-8.02	7.27	-2.58	-0.87	-3.27	7.92
Altman's Z-Score	- -	- -	- -	- -	- -	- -	- -	49.93	9.83	34.33	11.56	5.9	1.69	-1.63	2.97

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Accounts Receivable Turnover	0.36	0.18	6.88	4.67	- -	4.22	439.89	81.7	341.44	116.75	24.91	41.7	341.47	- -	243.1
Days Sales Outstanding	1,027.46	2,010.15	53.05	78.21	- -	86.45	0.83	4.47	1.07	3.13	14.65	8.75	1.07	- -	1.5
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	1,589	1,741	3,591	6,507	3,480	2,932	2,384	4,601
- Cash & Cash Equivalents	8	3	19	133	81	85	25	30	222	144	184	108	111	76	89
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	-1	-2	-1	-1	-1	-1	-1	-1	- -	- -	20	16	6	37
+ Total Debt	1	2	2	1	1	3	3	2	- -	21	26	82	115	511	366
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	1,514	1,482	3,297	6,165	3,205	2,659	2,219	4,085
Total Capital	13	11	28	167	110	98	83	98	244	483	434	500	402	702	870
Total Debt/Capital (%)	4.61	21.67	8.22	0.61	0.69	2.79	3.04	2.38	- -	4.38	5.88	16.32	28.63	72.77	42.12
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.01	- -	0.03	0.04	0.23	0.09
EV/Sales	- -	- -	- -	- -	- -	- -	- -	93.78	8.78	37.47	44.58	13.18	11.05	625.03	4.92
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	22.58	- -	- -	- -	- -	- -	33.41
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	24.22	- -	- -	- -	- -	- -	41.54
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	8.56	- -	- -	- -	- -	- -	17.62
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	9.2	- -	- -	- -	- -	- -	19.53
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	1,501	1,798	3,533	6,471	3,480	2,932	2,296	4,535
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	1,427	1,538	3,239	6,128	3,205	2,659	2,131	4,019
EV per Share	- -	- -	- -	- -	- -	- -	- -	17.11	15.52	32.2	59.09	30.25	24.78	17.85	30.1
TTM Sales	- -	- -	- -	- -	- -	- -	31	16	169	88	138	243	241	4	829
TTM EBITDA	-10	-19	-23	-52	-94	-78	-32	-51	66	-87	-141	-168	-193	-582	122
TTM Operating Income	-10	-21	-23	-51	-96	-80	-37	-56	61	-93	-149	-179	-205	-601	98
TTM Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	173	- -	- -	- -	- -	- -	232
TTM Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	161	- -	- -	- -	- -	- -	209

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	-30.86	11.16	-32.79	43.8	-18.42	-8.87	-3.8	28.9
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	24.22	- -	- -	- -	- -	- -	41.54
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	1,514	1,482	3,297	6,165	3,205	2,659	2,219	4,085
Low Price	- -	- -	- -	- -	- -	- -	- -	5.16	12.68	35.08	59.29	30.92	23.13	19.13	9.7
EV/Sales	- -	- -	- -	- -	- -	- -	- -	93.78	8.78	37.47	44.58	13.18	11.05	625.03	4.92
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	22.58	- -	- -	- -	- -	- -	33.41
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	25.17	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	23.02	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	27.2	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	17.51	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	16.58	7.12	7.78	15.92	8.73	10.8	12.86	9.87
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	7	6.51	9.76	18.73	14.4	12.81	17.97	5.49
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	17.63	7.69	10.67	23.52	22.06	16.56	26.69	10
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	4.77	4.95	7.78	15.13	8.22	9.15	12.83	2.83
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	20.62	7.65	8.04	16.47	9	11.23	13.48	10.02
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	8.71	7	10.09	19.37	14.85	13.32	18.84	5.57
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	21.92	8.27	11.04	24.33	22.74	17.21	27.98	10.15
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	5.93	5.32	8.04	15.65	8.47	9.51	13.45	2.87
Price/Sales	- -	- -	- -	- -	- -	- -	- -	93	10.14	40.15	46.79	14.31	12.18	646.65	5.47
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	39.28	9.27	50.38	55.05	23.59	14.44	903.82	3.04
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	98.86	10.95	55.12	69.14	36.14	18.66	1,342.22	5.54
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	26.74	7.05	40.15	44.48	13.47	10.31	645.3	1.56
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	-31.79	9.89	-36.88	37.77	-25.57	-19.05	-4.96	25.26
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	-13.43	9.04	-46.27	44.44	-42.16	-22.59	-6.93	14.03
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	-33.79	10.69	-50.62	55.81	-64.57	-29.19	-10.3	25.59
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	-9.14	6.88	-36.88	35.91	-24.06	-16.13	-4.95	7.23
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	-13.04	10.21	-41.14	51.53	-30.38	-10.52	-5.31	16.06
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	-32.81	12.06	-45.01	64.71	-46.53	-13.59	-7.89	29.28
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	-8.87	7.76	-32.79	41.64	-17.34	-7.51	-3.79	8.27
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	36.94	7.9	47.86	52.89	22.46	13.31	892.06	2.46
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	99.98	9.61	52.68	67.05	35.01	17.53	1,347.26	5
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	23.66	5.64	37.47	42.26	12.34	9.18	623.63	0.97
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	20.31	- -	- -	- -	- -	- -	16.69
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	24.72	- -	- -	- -	- -	- -	33.9
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	14.5	- -	- -	- -	- -	- -	6.55
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	21.78	- -	- -	- -	- -	- -	20.75
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	26.51	- -	- -	- -	- -	- -	42.15
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	15.55	- -	- -	- -	- -	- -	8.15
Last Price	- -	- -	- -	- -	- -	- -	- -	17.95	18.23	35.08	62.37	32.85	27.32	19.17	33.9
High Price	- -	- -	- -	- -	- -	- -	- -	19.08	19.7	48.15	92.15	82.95	41.86	39.79	34.35
Enterprise Value Average	- -	- -	- -	- -	- -	- -	- -	596	1,333	4,211	7,314	5,464	3,204	3,168	2,041
Enterprise Value High	- -	- -	- -	- -	- -	- -	- -	1,614	1,622	4,635	9,272	8,514	4,220	4,784	4,145
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	382	952	3,297	5,844	3,001	2,210	2,215	801

Shares Outstanding	9	14	32	55	60	70	75	89	96	102	104	106	107	124	136
Diluted Weighted Avg Shares	7	11	24	47	57	61	74	84	99	101	104	106	107	120	134
Basic Weighted Avg Shares	7	11	24	47	57	61	74	84	94	101	104	106	107	120	134
Revenue per Share	0.04	0.01	0.01	- -	0.01	- -	0.43	0.19	1.8	0.87	1.33	2.3	2.24	0.03	6.2
EBITDA per Share	-1.33	-1.74	-0.95	-1.11	-1.63	-1.29	-0.44	-0.61	0.7	-0.87	-1.36	-1.59	-1.79	-4.86	0.91
Operating Income per Share	-1.37	-1.89	-0.97	-1.09	-1.67	-1.31	-0.5	-0.67	0.65	-0.92	-1.44	-1.68	-1.91	-5.02	0.74
Basic EPS, GAAP	-0.44	-1.9	-1.3	-1.25	-1.6	-1.34	-0.47	-0.65	0.72	-0.84	-1.36	-1.66	-1.91	-5	-0.01
Basic EPS from Cont Ops	-1.22	-1.99	-1.32	-1.25	-1.6	-1.34	-0.47	-0.65	0.72	-0.84	-1.36	-1.67	-1.95	-5.09	0.23
Diluted EPS, GAAP	-0.44	-1.9	-1.3	-1.25	-1.6	-1.34	-0.47	-0.65	0.69	-0.84	-1.36	-1.66	-1.91	-5	-0.01
Diluted EPS from Cont Ops	-1.22	-1.99	-1.32	-1.25	-1.6	-1.34	-0.47	-0.65	0.69	-0.84	-1.36	-1.67	-1.95	-5.09	0.23
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.75	-1.38	-0.79	-0.75	-1.15	-1.06	-0.32	-0.56	1.84	-0.95	1.65	-1.28	-1.43	-3.86	1.34
Free Cash Flow per Basic Share	-0.75	-1.42	-0.81	-0.79	-1.18	-1.12	-0.43	-0.58	1.72	-1.07	1.42	-1.78	-3.08	-5.05	1.17
Cash & Equivalents per Share	0.94	0.26	0.87	2.82	1.66	1.22	0.88	0.86	2.71	3.08	3.53	3.55	3.76	5.48	6.77
Book Value per Share	1.48	0.74	0.85	3.05	1.85	1.37	1.09	1.08	2.56	4.51	3.92	3.76	2.53	1.49	3.43
Tangible Book Value per Share	1.28	0.39	0.75	3.03	1.43	1.05	0.82	0.87	2.38	4.36	3.79	3.65	2.43	1.42	3.38

Arrowhead Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)